Kenry is an Assistant Professor in Pharmaceutical Sciences at the Department of Pharmacology and Toxicology of the University of Arizona. His current research focuses on the bioinspired and data-driven design and development of micro/nanoscale platform tools to harness immune system to enable more personalized, targeted, and safer detection and treatment of cancer. To date, Kenry has authored/co-authored more than 60 peer-reviewed journal articles and his research has been recognized with numerous awards and honors, notably from the American Association for Cancer Research, American Chemical Society, Biomedical Engineering Society, European Materials Research Society, Japan Society for the Promotion of Science, and ASEAN Federation of Engineering Organization.
Kenry is currently an Assistant Professor in Pharmaceutical Sciences at the Department of Pharmacology and Toxicology of the University of Arizona. Prior to this, he carried out his postdoctoral work at Harvard University and Dana-Farber Cancer Institute. Kenry received his PhD in Biomedical Engineering from the National University of Singapore and BEng (First Class Honors) in Electrical and Electronic Engineering from Nanyang Technological University, Singapore. The Kenry Lab at the University of Arizona seeks to improve patient outcome and health by addressing various unmet needs in cancer diagnosis and treatment. Leveraging its expertise in nanomaterials, microfluidics, bioimaging, immunotherapy, and machine learning, the Kenry Lab adopts bioinspired and data-driven approaches to build novel micro/nanoscale platform tools and models to enable more personalized, targeted, and safer detection and treatment of cancer. Lab website: http://www.drkenry.com.